Reproducibility of serum cytokines and growth factors

Cytokine

Volumn 45, Issue 1, 2009, Pages 44-49

  Gu, Yian ^a   Zeleniuch Jacquotte, Anne ^a   Linkov, Faina ^b   Koenig, Karen L ^a   Liu, Mengling ^a   Velikokhatnaya, Lyudmila ^b   Shore, Roy E ^c   Marrangoni, Adele ^b   Toniolo, Paolo ^a   Lokshin, Anna E ^b   Arslan, Alan A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

C reactive protein; Cytokines; Growth factors; Interleukins; Reproducibility

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN DERIVATIVE; NERVE GROWTH FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; POSTMENOPAUSE; RANDOM ALLOCATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 57749097358     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.10.014     Document Type: Article

References (40)

1. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
2. Shacter E., and Weitzman S.A. Chronic inflammation and cancer. Oncology 16 (2002) 217-226
3. Macarthur M., Hold G.L., and El Omar E.M. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286 (2004) G515-G520
4. Il'yasova D., Colbert L.H., Harris T.B., Newman A.B., Bauer D.C., Satterfield S., et al. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 14 (2005) 2413-2418
5. Lin W.W., and Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117 (2007) 1175-1183
6. Shrout P.E., and Fleiss J.L. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86 (1979) 420-428
7. Aderka D., Engelmann H., Shemer-Avni Y., Hornik V., Galil A., Sarov B., et al. Variation in serum levels of the soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res 11 (1992) 157-159
8. Rao K.M., Pieper C.S., Currie M.S., and Cohen H.J. Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am J Clin Pathol 102 (1994) 802-805
9. Dugue B., and Leppanen E. Short-term variability in the concentration of serum interleukin-6 and its soluble receptor in subjectively healthy persons. Clin Chem Lab Med 36 (1998) 323-325
10. Cava F., Gonzalez C., Pascual M.J., Navajo J.A., and Gonzalez-Buitrago J.M. Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2R) in serum of healthy individuals. Cytokine 12 (2000) 1423-1425
11. Gonzalez C., Cava F., Ayllon A., Guevara P., Navajo J.A., and Gonzalez-Buitrago J.M. Biological variation of interleukin-1beta, interleukin-8 and tumor necrosis factor-alpha in serum of healthy individuals. Clin Chem Lab Med 39 (2001) 836-841
12. Lang U.E., Gallinat J., Danker-Hopfe H., Bajbouj M., and Hellweg R. Nerve growth factor serum concentrations in healthy human volunteers: physiological variance and stability. Neurosci Lett 344 (2003) 13-16
13. Ho G.Y., Xue X.N., Burk R.D., Kaplan R.C., Cornell E., and Cushman M. Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2 years in young women. Cytokine 30 (2005) 1-6
14. Kaplan R.C., Ho G.Y., Xue X., Rajpathak S., Cushman M., Rohan T.E., et al. Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Biomarkers Prev 16 (2007) 1291-1293
15. Lee S.A., Kallianpur A., Xiang Y.B., Wen W., Cai Q., Liu D., et al. Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev 16 (2007) 2464-2470
16. Kellar K.L., Kalwar R.R., Dubois K.A., Crouse D., Chafin W.D., and Kane B.E. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 45 (2001) 27-36
17. Sites C.K., Toth M.J., Cushman M., L'Hommedieu G.D., Tchernof A., Tracy R.P., et al. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril 77 (2002) 128-135
18. Vignali D.A. Multiplexed particle-based flow cytometric assays. J Immunol Methods 243 (2000) 243-255
19. Little J.A. Comparison of curve fitting models for ligand binding assays. Chromatographia 59 (2004) S177-S181
20. McGraw K.O., and Wong S.P. Forming inferences about some intraclass correlation coefficients. Psychol Methods 1 (1996) 30-46
21. Koenig K.L., Toniolo P., Bruning P.F., Bonfrer J.M., Shore R.E., and Pasternack B.S. Reliability of serum prolactin measurements in women. Cancer Epidemiol Biomarkers Prev 2 (1993) 411-414
22. Toniolo P., Koenig K.L., Pasternack B.S., Banerjee S., Rosenberg C., Shore R.E., et al. Reliability of measurements of total, protein-bound, and unbound estradiol in serum. Cancer Epidemiol Biomarkers Prev 3 (1994) 47-50
23. Arslan A.A., Zeleniuch-Jacquotte A., Lukanova A., Rinaldi S., Kaaks R., and Toniolo P. Reliability of follicle-stimulating hormone measurements in serum. Reprod Biol Endocrinol 1 (2003) 49
24. Willett W. Nutritional epidemiology. 2nd ed. (1998), Oxford University Press, New York, NY
25. Hankinson S.E., Manson J.E., Spiegelman D., Willett W.C., Longcope C., and Speizer F.E. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 4 (1995) 649-654
26. Zeleniuch-Jacquotte A., Shore R.E., Koenig K.L., Akhmedkhanov A., Afanasyeva Y., Kato I., et al. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer 90 (2004) 153-159
27. Rosner B., Willett W.C., and Spiegelman D. Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error. Stat Med 8 (1989) 1051-1069
28. Cannon J.G., and Dinarello C.A. Increased plasma interleukin-1 activity in women after ovulation. Science 227 (1985) 1247-1249
29. Friedman H. Alcohol effects on cytokine responses by immunocytes. Alcohol Clin Exp Res 22 (1998) 184S-187S
30. McIlhenny C., George W.D., and Doughty J.C. A comparison of serum and plasma levels of vascular endothelial growth factor during the menstrual cycle in healthy female volunteers. Br J Cancer 86 (2002) 1786-1789
31. Rehman J.C. Obesity is associated with increased levels of circulating hepatocyte growth factor. J Am Coll Cardiol 41 (2003) 1408-1413
32. Ledur A., Fitting C., David B., Hamberger C., and Cavaillon J.M. Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards. J Immunol Methods 186 (1995) 171-179
33. Aziz N., Nishanian P., Mitsuyasu R.T., Detels R., and Fahey J.L. Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol 6 (1999) 89-95
34. duPont N.C., Wang K., Wadhwa P.D., Culhane J.F., and Nelson E.L. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 66 (2005) 175-191
35. Thorpe R., Wadhwa M., Bird C.R., and Mire-Sluis A.R. Detection and measurement of cytokines. Blood Rev 6 (1992) 133-148
36. Otten U., and Gadient R.A. Neurotrophins and cytokines-intermediaries between the immune and nervous systems. Int J Dev Neurosci 13 (1995) 147-151
37. Bonini S., Lambiase A., Bonini S., Angelucci F., Magrini L., Manni L., et al. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 93 (1996) 10955-10960
38. Bonini S., Rasi G., Bracci-Laudiero M.L., Procoli A., and Aloe L. Nerve growth factor: neurotrophin or cytokine?. Int Arch Allergy Immunol 131 (2003) 80-84
39. van der Poll T., van Deventer S.J., ten Cate H., Levi M., and ten Cate J.W. Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia. J Infect Dis 169 (1994) 665-667
40. Moshage H.J., Roelofs H.M., van Pelt J.F., Hazenberg B.P., van Leeuwen M.A., Limburg P.C., et al. The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun 155 (1988) 112-117